Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Alder BioPharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alder BioPharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ChemoCentryx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChemoCentryx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fate Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fate Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nabriva Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nabriva Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Neos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoMed Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoMed Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TG Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TG Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ADMA Biologics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ADMA Biologics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Altimmune Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Altimmune Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Chimerix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Chimerix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

EyeGate Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

EyeGate Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tocagen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tocagen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Dermira, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Dermira, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ENDRA Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ENDRA Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regenxbio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenxbio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Capricor Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Capricor Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Concert Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Concert Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Novocure Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novocure Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Syndax Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Syndax Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aduro Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aduro Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bellicum Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bellicum Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

FibroGen Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

FibroGen Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ocular Therapeutix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocular Therapeutix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Editas Medicine Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Editas Medicine Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PLx Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PLx Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agios Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agios Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Wave Life Sciences Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Wave Life Sciences Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Karyopharm Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Karyopharm Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Phibro Animal Health Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Phibro Animal Health Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ionis Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ionis Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Xenon Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xenon Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AnaptysBio Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AnaptysBio Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ANI Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ANI Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ProQR Therapeutics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProQR Therapeutics NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vaxart, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vaxart, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Eagle Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Eagle Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Mediwound Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediwound Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ascendis Pharma AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascendis Pharma AS Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pulmatrix Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmatrix Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Quotient Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quotient Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aratana Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aratana Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cellular Biomedicine Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cellular Biomedicine Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cerecor Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cerecor Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Natera Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natera Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Theravance Biopharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Biopharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Blueprint Medicines Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Blueprint Medicines Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

GlycoMimetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

GlycoMimetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Millendo Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millendo Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Bioverativ Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bioverativ Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Molecular Templates Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Templates Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1